Capstone Therapeutics Corp. Intellectual Property Contracts & Agreements
6 Contracts & Agreements
- License Agreements (6 contracts)
- License Agreement dated May 2, 2018, by and between LipimetiX Development, Inc. and ANJI Pharmaceuticals Inc (Filed With SEC on May 7, 2018)
- SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on January 30, 2015)
- EXHIBIT 10.3EXECUTION FIRST AMENDMENT AND CONSENT TO ASSIGNMENT OF EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 10, 2012)
- The expected increased value from having all Chrysalin patent license rights owned by a single entity rather than having multiple owners of rights for different indications (Filed With SEC on June 3, 2004)
- The expected increased value from having all Chrysalin patent license rights owned by a single entity rather than having multiple owners of rights for different indications (Filed With SEC on June 3, 2004)
- The expected increased value from having all Chrysalin patent license rights owned by a single entity rather than having multiple owners of rights for different indications (Filed With SEC on June 3, 2004)
